Tags:

Eyelash Enhancer Works on Scalp, Too

Monday, 09 May 2011 08:58 AM

An increasing number of balding men are experimenting with Latisse, a prescription eyelash-enhancing product, to treat their receding hairlines.

“I just put three or four drops on each side of my temple once a day,” Richard Paduda, 32, an insurance worker from Boca Raton, Fla., tells the New York Times. “The hair in that area, which was real thin and wispy — all those hairs got thick again, dark.”

Paduda’s enthusiasm for the product is part of the chatter that began in dermatologists’ offices and websites for those with balding woes soon after the Food and Drug Administration approved Latisse by Allergan for eyelash use in December 2008, according to the paper.

Dr. Alan Bauman, a dermatologist and hair-restoration specialist, said he has been prescribing a generic form of bimatoprost, the active ingredient in Latisse, to battle hair loss since 2007, and that it has worked for about 70 percent of his patients.

However, despite its reported success, Latisse is no cure-all. Like minoxidil and finasteride, the only FDA-approved drugs for hair-loss treatment, Latisse cannot revive a dying hair follicle, although it can strengthen and darken hair growing from it.

“What we found is that where patients were applying Latisse, especially in areas where the hair was thinner and wispier and less pigmented, the hair grew thicker, stronger and healthier,” Bauman says.

To read the complete New York Times story, Go Here Now.



© HealthDay

 
1Like our page
2Share
Health-News
233
2011-58-09
Monday, 09 May 2011 08:58 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved